Literature DB >> 26938650

Current Status of Brain Tumor Surveillance in Canada and Why it Matters.

Faith Davis, Chenthila Nagamuthu, Jordan Ross, Joseph Megyesi.   

Abstract

The Brain Tumor Foundation of Canada has identified developing a pan-Canadian report on all primary brain tumors as a priority. The objective of this report is to present the history and rationale underlying reporting of brain tumors and to summarize the current status of brain tumor data collection and reporting in Canadian registries. We reviewed the literature on reporting history and rationale, conducted a survey of cancer registries across Canada, and reviewed cancer registry websites and Canadian Cancer Statistics Reports for publicly available descriptive statistics. A brain tumor surveillance system that includes data on both malignant and benign brain tumors is feasible within Canada and will include approximately twice the number of malignant cases currently reported. Once patterns of brain tumors become available, clinicians, researchers, and policy makers will have a clearer understanding of disease burden and how Canadian survival outcomes fare across regions and against other nations. Collaborative efforts on the part of cancer registry and neurooncology stakeholders will serve to enhance the quality and utility of this information for improving the overall patient experience.

Entities:  

Mesh:

Year:  2015        PMID: 26938650

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  3 in total

1.  Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015.

Authors:  Faith G Davis; Trenton R Smith; Haley R Gittleman; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

2.  Incidence and prevalence of primary malignant brain tumours in Canada from 1992 to 2017: an epidemiologic study.

Authors:  Mathew R Voisin; Sanskriti Sasikumar; Alireza Mansouri; Gelareh Zadeh
Journal:  CMAJ Open       Date:  2021-11-09

3.  Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.

Authors:  Emily V Walker; Faith G Davis
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.